首页> 美国政府科技报告 >Preclinical Toxicologic Evaluation of Bruceantin (NSC-165,563) in Dogs
【24h】

Preclinical Toxicologic Evaluation of Bruceantin (NSC-165,563) in Dogs

机译:布鲁西汀(NsC-165,563)在犬中的临床前毒理学评价

获取原文

摘要

The infusion of Bruceantin as single dose of 1.25 (0.0625) or 0.312 (0.0156) mg/sq. m. (mg/kg) or as five daily doses of 0.626 (0.0313) mg/sq. m./day (mg/kg/day) was not toxic to dogs. Though traces of occult fecal blood were observed after treatment, evidence in dicated that this observation was a false positive and reflected the presence of peroxidase-like activity from sources other than blood. A few hematologic changes (leukopenia, thrombocytopenia, and anemia) were also noted, but none appeared to be related to treatment. These studies support the authors previous conclusion that 1.25 mg/sq. m./day is the HNTD (highest nontoxic dose) for single or five daily doses of Bruceantin.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号